134 results
Page 5 of 7
8-K
EX-99.1
njfcobnh
19 Jun 20
Patent License Agreement
5:26pm
8-K
7a1sm
15 Jun 20
Entry into a Material Definitive Agreement
4:13pm
8-K
3n2cp
29 May 20
Vir Biotechnology and Biogen Execute Agreement to ManufactureSARS-CoV-2 Antibodies for PotentialCOVID-19 Treatment
4:06pm
8-K
EX-99.1
faykc206u
29 May 20
Vir Biotechnology and Biogen Execute Agreement to ManufactureSARS-CoV-2 Antibodies for PotentialCOVID-19 Treatment
4:06pm
8-K
EX-99.1
3gse0rcyv iw
12 May 20
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2020 Financial Results
4:05pm
8-K
w135w 6x60zx87
10 Apr 20
Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture ofSARS-COV-2 Antibodies for Potential COVID-19 Treatment
8:01am
8-K
EX-99.1
9tlv6omqjeg18gs9
10 Apr 20
Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture ofSARS-COV-2 Antibodies for Potential COVID-19 Treatment
8:01am
DEF 14A
2xklk1n28vuak42
6 Apr 20
Definitive proxy
4:52pm
8-K
EX-99.1
w41uojaof6
6 Apr 20
Entry into a Material Definitive Agreement
8:02am
8-K
qgyz mlbbkid535b6
6 Apr 20
Entry into a Material Definitive Agreement
8:02am
10-K
vab8cz5ilyp3cq5 y7i7
26 Mar 20
Annual report
4:08pm
8-K
EX-99.1
cb2 qb4uj2ew7rg
26 Mar 20
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2019 Financial Results
4:01pm
8-K
EX-99.1
2tdzt s4a66
12 Feb 20
Vir Biotechnology Identifies Two Antibodies That Bind to The Spike Protein of
5:02pm
8-K
oqtb003d 3i
30 Jan 20
Other Events
6:07am
8-K
EX-99.1
y2ywli6uaphtkkuh3qm
23 Jan 20
Other Events
6:08am
10-Q
m9rax9 o6et
19 Nov 19
Quarterly report
4:06pm
8-K
EX-99.1
ax3u8 76g
19 Nov 19
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2019 Financial Results
4:05pm
S-8
enhexdlvir9u35
15 Oct 19
Registration of securities for employees
4:47pm
S-8
EX-4.8
tjwl0d 4vl2uy
15 Oct 19
Registration of securities for employees
4:47pm